tebipenem: Clinical Trials

7 trials of tebipenem, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7

Follow tebipenem: new trials by email Literature Review of tebipenem trials Research Report on tebipenem

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants
TBP-PI-HBr - Healthy Participants
Phase 1CompletedSpero Therapeutics392024-11-202025-05-20
A Study to Compare Two Bioanalytical Assays for Tebipenem
TBP-PI-HBr - Healthy Volunteers
Phase 1CompletedSpero Therapeutics202023-05-042024-03-27
Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers
TBPM-PI-HBr - Healthy Volunteers
Phase 1CompletedSpero Therapeutics302020-12-072021-03-16
Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr), 20 mL aluminum hydroxide/magnesium hydroxide/simethicone (400 mg aluminum hydroxide/400 mg magnesium hydroxide/40 mg simethicone per 5 mL), Omeprazole - Healthy Volunteers
Phase 1CompletedSpero Therapeutics202020-07-012020-09-04
A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects
Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo, Moxifloxacin 400mg, Placebo for Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) - TQT Study
Phase 1CompletedSpero Therapeutics242020-01-192020-03-13
Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function
Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - Renal Impairment
Phase 1CompletedSpero Therapeutics392019-12-062020-11-27
Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994
SPR994, Placebo Oral Tablet, Orapenem® - Healthy Volunteers
Phase 1CompletedSpero Therapeutics1242017-10-202018-08-28

Conditions studied

Kidney Diseases (1)  ·  Renal Insufficiency (1)

Sponsors

Spero Therapeutics (7)

Countries

United States (6)  ·  Australia (1)

Top investigators

David Melnick, M.D. (2)  ·  Charlotte Lemech, FRACP, MD (1)  ·  David Baratz, MD (1)

Results publications

PMID 31262768, PMID 35420493, PMID 35762796